Industry Insights

Healthesystems' clinicians, data analysts, compliance officers, and business leaders are at the forefront of the issues and events that affect the workers’ compensation and healthcare industries.
Drawing on their expertise and insights, Healthesystems produces and publishes a variety of educational resources that help workers' compensation professionals stay informed and gain a deeper understanding of:
New drugs and other pharmacological updates
Medical equipment and service developments
Population demographics
Regulatory and policy news
Business, industry, and cultural trends

RxInformer

Award-winning journal providing in-depth analysis on today’s most important topics

Ask a Clinician: What Is the Difference Between Physical and Occupational Therapies?

Healthe's clinicians tackle common workers' comp questions
Winter 2021/2022

Classification Complications: Will Gig Workers Enter the Workers’ Comp Market?

Legislation could reclassify gig workers as employees, which could entitle them to benefits
Winter 2021/2022

The Long Haul: Chronic Health Complications of COVID-19

Those previously infected by coronavirus may face long-term health complications, potentially complicating workers' comp claims
Winter 2021/2022

Workers' Comprehensive

Monthly e-newsletter covering news stories relevant to workers’ compensation

CDC Updates Isolation and Quarantine Period for COVID-19

New five-day rules are recommended, with variation depending upon vaccination status.
Jan 2022

The Great Resignation Continues to Impact Workforce Dynamics

The Bureau of Labor Statistics reports that 4.5 million employees quit their jobs in November 2021.
Jan 2022

4 Ways to Manage Medical Supply Chain Disruption in Workers’ Comp

Healthe’s SVP of Product Strategy and Innovation, Kristine Kennedy, discusses this topic with Risk & Insurance magazine.
Jan 2022

Clinical Guidance

“Clinical Minute” videos and other helpful resources from our clinical experts

Update on Antibody Testing

Testing for COVID-19 antibodies is not a conclusive test for infection.
Apr 2020

FDA Authorizes First COVID-19 Test for At-Home Sample Collection

This is NOT an at-home test. Samples collected at home must be sent to a LabCorp facility.
Apr 2020
1 2 3 4

Whitepapers

lockenvelopephone-handsetmenucross-circle